Trispecific antibodies are rapidly emerging as the next-generation modality in immunotherapy, offering a transformative approach to targeting cancer and other diseases. These engineered molecules can simultaneously interact with three different targets—whether antigens or immune cells—leading to improved specificity and enhanced therapeutic activity, particularly in oncology....
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek